 | • レポートコード：MRC2Q12-03603 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、ソラフェニブAPIの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にソラフェニブAPIのグローバル市場のxxx％を占める「0.99」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「錠剤」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 ソラフェニブAPIの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのソラフェニブAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ソラフェニブAPIのグローバル主要プレイヤーには、Hunan Huateng Pharmaceutical、Anhui HaiKang Pharmaceutical、Chongqing Carelife Pharmaceutical、Sichuan Xieli Pharmaceutical、NEWEDGE Overseas、KriSan Biotech、Teva API、Alembic Pharmaceuticals、Aurobindo Pharma、BDR Pharmaceuticals、Biotechnica Pharma Global、Bulat Pharmaceutical、Cdymax、Estechpharma、Jeil Pharmaceutical、MSN Laboratories、Stason Pharmaceuticals、Vannsh Life Sciencesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ソラフェニブAPI市場は、種類と用途によって区分されます。世界のソラフェニブAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 0.99、0.995、0.999、その他 【用途別セグメント】 錠剤、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ソラフェニブAPI製品概要 - 種類別市場（0.99、0.995、0.999、その他） - 用途別市場（錠剤、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のソラフェニブAPI販売量予測2017-2028 - 世界のソラフェニブAPI売上予測2017-2028 - ソラフェニブAPIの地域別販売量 - ソラフェニブAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ソラフェニブAPI販売量 - 主要メーカー別ソラフェニブAPI売上 - 主要メーカー別ソラフェニブAPI価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（0.99、0.995、0.999、その他） - ソラフェニブAPIの種類別販売量 - ソラフェニブAPIの種類別売上 - ソラフェニブAPIの種類別価格 ・用途別市場規模（錠剤、その他） - ソラフェニブAPIの用途別販売量 - ソラフェニブAPIの用途別売上 - ソラフェニブAPIの用途別価格 ・北米市場 - 北米のソラフェニブAPI市場規模（種類別、用途別） - 主要国別のソラフェニブAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのソラフェニブAPI市場規模（種類別、用途別） - 主要国別のソラフェニブAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のソラフェニブAPI市場規模（種類別、用途別） - 主要国別のソラフェニブAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のソラフェニブAPI市場規模（種類別、用途別） - 主要国別のソラフェニブAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのソラフェニブAPI市場規模（種類別、用途別） - 主要国別のソラフェニブAPI市場規模（トルコ、サウジアラビア） ・企業情報 Hunan Huateng Pharmaceutical、Anhui HaiKang Pharmaceutical、Chongqing Carelife Pharmaceutical、Sichuan Xieli Pharmaceutical、NEWEDGE Overseas、KriSan Biotech、Teva API、Alembic Pharmaceuticals、Aurobindo Pharma、BDR Pharmaceuticals、Biotechnica Pharma Global、Bulat Pharmaceutical、Cdymax、Estechpharma、Jeil Pharmaceutical、MSN Laboratories、Stason Pharmaceuticals、Vannsh Life Sciences ・産業チェーン及び販売チャネル分析 - ソラフェニブAPIの産業チェーン分析 - ソラフェニブAPIの原材料 - ソラフェニブAPIの生産プロセス - ソラフェニブAPIの販売及びマーケティング - ソラフェニブAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ソラフェニブAPIの産業動向 - ソラフェニブAPIのマーケットドライバー - ソラフェニブAPIの課題 - ソラフェニブAPIの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Sorafenib API estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Sorafenib API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Sorafenib API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Sorafenib API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Sorafenib API include Hunan Huateng Pharmaceutical, Anhui HaiKang Pharmaceutical, Chongqing Carelife Pharmaceutical, Sichuan Xieli Pharmaceutical, NEWEDGE Overseas, KriSan Biotech, Teva API, Alembic Pharmaceuticals and Aurobindo Pharma, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Sorafenib API production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Sorafenib API by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Sorafenib API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Sorafenib API market. Further, it explains the major drivers and regional dynamics of the global Sorafenib API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Hunan Huateng Pharmaceutical
Anhui HaiKang Pharmaceutical
Chongqing Carelife Pharmaceutical
Sichuan Xieli Pharmaceutical
NEWEDGE Overseas
KriSan Biotech
Teva API
Alembic Pharmaceuticals
Aurobindo Pharma
BDR Pharmaceuticals
Biotechnica Pharma Global
Bulat Pharmaceutical
Cdymax
Estechpharma
Jeil Pharmaceutical
MSN Laboratories
Stason Pharmaceuticals
Vannsh Life Sciences
Market Segments
This report has explored the key segments: by Purity and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Sorafenib API Segment by Purity
0.99
0.995
0.999
Others
Sorafenib API Segment by Application
Tablets
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Sorafenib API production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Sorafenib API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Sorafenib API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Sorafenib API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Sorafenib API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sorafenib API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Sorafenib API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Sorafenib API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Hunan Huateng Pharmaceutical, Anhui HaiKang Pharmaceutical, Chongqing Carelife Pharmaceutical, Sichuan Xieli Pharmaceutical, NEWEDGE Overseas, KriSan Biotech, Teva API, Alembic Pharmaceuticals and Aurobindo Pharma, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sorafenib API capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Sorafenib API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Sorafenib API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by purity, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by purity, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by purity, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by purity, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by purity, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sorafenib API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Sorafenib API Product Introduction
1.2 Market by Purity
1.2.1 Global Sorafenib API Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 0.99
1.2.3 0.995
1.2.4 0.999
1.2.5 Others
1.3 Market by Application
1.3.1 Global Sorafenib API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Tablets
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Sorafenib API Production
2.1 Global Sorafenib API Production Capacity (2017-2028)
2.2 Global Sorafenib API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Sorafenib API Production by Region
2.3.1 Global Sorafenib API Historic Production by Region (2017-2022)
2.3.2 Global Sorafenib API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Sorafenib API Sales in Volume & Value Estimates and Forecasts
3.1 Global Sorafenib API Sales Estimates and Forecasts 2017-2028
3.2 Global Sorafenib API Revenue Estimates and Forecasts 2017-2028
3.3 Global Sorafenib API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Sorafenib API Sales by Region
3.4.1 Global Sorafenib API Sales by Region (2017-2022)
3.4.2 Global Sales Sorafenib API by Region (2023-2028)
3.5 Global Sorafenib API Revenue by Region
3.5.1 Global Sorafenib API Revenue by Region (2017-2022)
3.5.2 Global Sorafenib API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Sorafenib API Production Capacity by Manufacturers
4.2 Global Sorafenib API Sales by Manufacturers
4.2.1 Global Sorafenib API Sales by Manufacturers (2017-2022)
4.2.2 Global Sorafenib API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Sorafenib API in 2021
4.3 Global Sorafenib API Revenue by Manufacturers
4.3.1 Global Sorafenib API Revenue by Manufacturers (2017-2022)
4.3.2 Global Sorafenib API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Sorafenib API Revenue in 2021
4.4 Global Sorafenib API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Sorafenib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Sorafenib API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Sorafenib API Sales by Purity
5.1.1 Global Sorafenib API Historical Sales by Purity (2017-2022)
5.1.2 Global Sorafenib API Forecasted Sales by Purity (2023-2028)
5.1.3 Global Sorafenib API Sales Market Share by Purity (2017-2028)
5.2 Global Sorafenib API Revenue by Purity
5.2.1 Global Sorafenib API Historical Revenue by Purity (2017-2022)
5.2.2 Global Sorafenib API Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Sorafenib API Revenue Market Share by Purity (2017-2028)
5.3 Global Sorafenib API Price by Purity
5.3.1 Global Sorafenib API Price by Purity (2017-2022)
5.3.2 Global Sorafenib API Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Sorafenib API Sales by Application
6.1.1 Global Sorafenib API Historical Sales by Application (2017-2022)
6.1.2 Global Sorafenib API Forecasted Sales by Application (2023-2028)
6.1.3 Global Sorafenib API Sales Market Share by Application (2017-2028)
6.2 Global Sorafenib API Revenue by Application
6.2.1 Global Sorafenib API Historical Revenue by Application (2017-2022)
6.2.2 Global Sorafenib API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Sorafenib API Revenue Market Share by Application (2017-2028)
6.3 Global Sorafenib API Price by Application
6.3.1 Global Sorafenib API Price by Application (2017-2022)
6.3.2 Global Sorafenib API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Sorafenib API Market Size by Purity
7.1.1 North America Sorafenib API Sales by Purity (2017-2028)
7.1.2 North America Sorafenib API Revenue by Purity (2017-2028)
7.2 North America Sorafenib API Market Size by Application
7.2.1 North America Sorafenib API Sales by Application (2017-2028)
7.2.2 North America Sorafenib API Revenue by Application (2017-2028)
7.3 North America Sorafenib API Sales by Country
7.3.1 North America Sorafenib API Sales by Country (2017-2028)
7.3.2 North America Sorafenib API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Sorafenib API Market Size by Purity
8.1.1 Europe Sorafenib API Sales by Purity (2017-2028)
8.1.2 Europe Sorafenib API Revenue by Purity (2017-2028)
8.2 Europe Sorafenib API Market Size by Application
8.2.1 Europe Sorafenib API Sales by Application (2017-2028)
8.2.2 Europe Sorafenib API Revenue by Application (2017-2028)
8.3 Europe Sorafenib API Sales by Country
8.3.1 Europe Sorafenib API Sales by Country (2017-2028)
8.3.2 Europe Sorafenib API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Sorafenib API Market Size by Purity
9.1.1 Asia Pacific Sorafenib API Sales by Purity (2017-2028)
9.1.2 Asia Pacific Sorafenib API Revenue by Purity (2017-2028)
9.2 Asia Pacific Sorafenib API Market Size by Application
9.2.1 Asia Pacific Sorafenib API Sales by Application (2017-2028)
9.2.2 Asia Pacific Sorafenib API Revenue by Application (2017-2028)
9.3 Asia Pacific Sorafenib API Sales by Region
9.3.1 Asia Pacific Sorafenib API Sales by Region (2017-2028)
9.3.2 Asia Pacific Sorafenib API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Sorafenib API Market Size by Purity
10.1.1 Latin America Sorafenib API Sales by Purity (2017-2028)
10.1.2 Latin America Sorafenib API Revenue by Purity (2017-2028)
10.2 Latin America Sorafenib API Market Size by Application
10.2.1 Latin America Sorafenib API Sales by Application (2017-2028)
10.2.2 Latin America Sorafenib API Revenue by Application (2017-2028)
10.3 Latin America Sorafenib API Sales by Country
10.3.1 Latin America Sorafenib API Sales by Country (2017-2028)
10.3.2 Latin America Sorafenib API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Sorafenib API Market Size by Purity
11.1.1 Middle East and Africa Sorafenib API Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Sorafenib API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Sorafenib API Market Size by Application
11.2.1 Middle East and Africa Sorafenib API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Sorafenib API Revenue by Application (2017-2028)
11.3 Middle East and Africa Sorafenib API Sales by Country
11.3.1 Middle East and Africa Sorafenib API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Sorafenib API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Hunan Huateng Pharmaceutical
12.1.1 Hunan Huateng Pharmaceutical Corporation Information
12.1.2 Hunan Huateng Pharmaceutical Overview
12.1.3 Hunan Huateng Pharmaceutical Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Hunan Huateng Pharmaceutical Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Hunan Huateng Pharmaceutical Recent Developments
12.2 Anhui HaiKang Pharmaceutical
12.2.1 Anhui HaiKang Pharmaceutical Corporation Information
12.2.2 Anhui HaiKang Pharmaceutical Overview
12.2.3 Anhui HaiKang Pharmaceutical Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Anhui HaiKang Pharmaceutical Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Anhui HaiKang Pharmaceutical Recent Developments
12.3 Chongqing Carelife Pharmaceutical
12.3.1 Chongqing Carelife Pharmaceutical Corporation Information
12.3.2 Chongqing Carelife Pharmaceutical Overview
12.3.3 Chongqing Carelife Pharmaceutical Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Chongqing Carelife Pharmaceutical Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Chongqing Carelife Pharmaceutical Recent Developments
12.4 Sichuan Xieli Pharmaceutical
12.4.1 Sichuan Xieli Pharmaceutical Corporation Information
12.4.2 Sichuan Xieli Pharmaceutical Overview
12.4.3 Sichuan Xieli Pharmaceutical Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Sichuan Xieli Pharmaceutical Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Sichuan Xieli Pharmaceutical Recent Developments
12.5 NEWEDGE Overseas
12.5.1 NEWEDGE Overseas Corporation Information
12.5.2 NEWEDGE Overseas Overview
12.5.3 NEWEDGE Overseas Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 NEWEDGE Overseas Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 NEWEDGE Overseas Recent Developments
12.6 KriSan Biotech
12.6.1 KriSan Biotech Corporation Information
12.6.2 KriSan Biotech Overview
12.6.3 KriSan Biotech Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 KriSan Biotech Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 KriSan Biotech Recent Developments
12.7 Teva API
12.7.1 Teva API Corporation Information
12.7.2 Teva API Overview
12.7.3 Teva API Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Teva API Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Teva API Recent Developments
12.8 Alembic Pharmaceuticals
12.8.1 Alembic Pharmaceuticals Corporation Information
12.8.2 Alembic Pharmaceuticals Overview
12.8.3 Alembic Pharmaceuticals Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Alembic Pharmaceuticals Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Alembic Pharmaceuticals Recent Developments
12.9 Aurobindo Pharma
12.9.1 Aurobindo Pharma Corporation Information
12.9.2 Aurobindo Pharma Overview
12.9.3 Aurobindo Pharma Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Aurobindo Pharma Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Aurobindo Pharma Recent Developments
12.10 BDR Pharmaceuticals
12.10.1 BDR Pharmaceuticals Corporation Information
12.10.2 BDR Pharmaceuticals Overview
12.10.3 BDR Pharmaceuticals Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 BDR Pharmaceuticals Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 BDR Pharmaceuticals Recent Developments
12.11 Biotechnica Pharma Global
12.11.1 Biotechnica Pharma Global Corporation Information
12.11.2 Biotechnica Pharma Global Overview
12.11.3 Biotechnica Pharma Global Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Biotechnica Pharma Global Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Biotechnica Pharma Global Recent Developments
12.12 Bulat Pharmaceutical
12.12.1 Bulat Pharmaceutical Corporation Information
12.12.2 Bulat Pharmaceutical Overview
12.12.3 Bulat Pharmaceutical Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Bulat Pharmaceutical Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Bulat Pharmaceutical Recent Developments
12.13 Cdymax
12.13.1 Cdymax Corporation Information
12.13.2 Cdymax Overview
12.13.3 Cdymax Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Cdymax Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Cdymax Recent Developments
12.14 Estechpharma
12.14.1 Estechpharma Corporation Information
12.14.2 Estechpharma Overview
12.14.3 Estechpharma Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Estechpharma Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Estechpharma Recent Developments
12.15 Jeil Pharmaceutical
12.15.1 Jeil Pharmaceutical Corporation Information
12.15.2 Jeil Pharmaceutical Overview
12.15.3 Jeil Pharmaceutical Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Jeil Pharmaceutical Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Jeil Pharmaceutical Recent Developments
12.16 MSN Laboratories
12.16.1 MSN Laboratories Corporation Information
12.16.2 MSN Laboratories Overview
12.16.3 MSN Laboratories Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 MSN Laboratories Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 MSN Laboratories Recent Developments
12.17 Stason Pharmaceuticals
12.17.1 Stason Pharmaceuticals Corporation Information
12.17.2 Stason Pharmaceuticals Overview
12.17.3 Stason Pharmaceuticals Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.17.4 Stason Pharmaceuticals Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Stason Pharmaceuticals Recent Developments
12.18 Vannsh Life Sciences
12.18.1 Vannsh Life Sciences Corporation Information
12.18.2 Vannsh Life Sciences Overview
12.18.3 Vannsh Life Sciences Sorafenib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.18.4 Vannsh Life Sciences Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Vannsh Life Sciences Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Sorafenib API Industry Chain Analysis
13.2 Sorafenib API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Sorafenib API Production Mode & Process
13.4 Sorafenib API Sales and Marketing
13.4.1 Sorafenib API Sales Channels
13.4.2 Sorafenib API Distributors
13.5 Sorafenib API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Sorafenib API Industry Trends
14.2 Sorafenib API Market Drivers
14.3 Sorafenib API Market Challenges
14.4 Sorafenib API Market Restraints
15 Key Finding in The Global Sorafenib API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Sorafenib API Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 0.99
Table 3. Major Manufacturers of 0.995
Table 4. Major Manufacturers of 0.999
Table 5. Major Manufacturers of Others
Table 6. Global Sorafenib API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 7. Global Sorafenib API Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 8. Global Sorafenib API Production by Region (2017-2022) & (Tons)
Table 9. Global Sorafenib API Production Market Share by Region (2017-2022)
Table 10. Global Sorafenib API Production by Region (2023-2028) & (Tons)
Table 11. Global Sorafenib API Production Market Share by Region (2023-2028)
Table 12. Global Sorafenib API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 13. Global Sorafenib API Sales by Region (2017-2022) & (Tons)
Table 14. Global Sorafenib API Sales Market Share by Region (2017-2022)
Table 15. Global Sorafenib API Sales by Region (2023-2028) & (Tons)
Table 16. Global Sorafenib API Sales Market Share by Region (2023-2028)
Table 17. Global Sorafenib API Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Sorafenib API Revenue Market Share by Region (2017-2022)
Table 19. Global Sorafenib API Revenue by Region (2023-2028) & (US$ Million)
Table 20. Global Sorafenib API Revenue Market Share by Region (2023-2028)
Table 21. Global Sorafenib API Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 22. Global Sorafenib API Capacity Market Share by Manufacturers (2017-2022)
Table 23. Global Sorafenib API Sales by Manufacturers (2017-2022) & (Tons)
Table 24. Global Sorafenib API Sales Market Share by Manufacturers (2017-2022)
Table 25. Global Sorafenib API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 26. Global Sorafenib API Revenue Share by Manufacturers (2017-2022)
Table 27. Sorafenib API Price by Manufacturers 2017-2022 (US$/Kg)
Table 28. Global Sorafenib API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Sorafenib API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sorafenib API as of 2021)
Table 30. Sorafenib API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Sorafenib API Product Offered
Table 32. Date of Manufacturers Enter into Sorafenib API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Sorafenib API Sales by Purity (2017-2022) & (Tons)
Table 35. Global Sorafenib API Sales by Purity (2023-2028) & (Tons)
Table 36. Global Sorafenib API Sales Share by Purity (2017-2022)
Table 37. Global Sorafenib API Sales Share by Purity (2023-2028)
Table 38. Global Sorafenib API Revenue by Purity (2017-2022) & (US$ Million)
Table 39. Global Sorafenib API Revenue by Purity (2023-2028) & (US$ Million)
Table 40. Global Sorafenib API Revenue Share by Purity (2017-2022)
Table 41. Global Sorafenib API Revenue Share by Purity (2023-2028)
Table 42. Sorafenib API Price by Purity (2017-2022) & (US$/Kg)
Table 43. Global Sorafenib API Price Forecast by Purity (2023-2028) & (US$/Kg)
Table 44. Global Sorafenib API Sales by Application (2017-2022) & (Tons)
Table 45. Global Sorafenib API Sales by Application (2023-2028) & (Tons)
Table 46. Global Sorafenib API Sales Share by Application (2017-2022)
Table 47. Global Sorafenib API Sales Share by Application (2023-2028)
Table 48. Global Sorafenib API Revenue by Application (2017-2022) & (US$ Million)
Table 49. Global Sorafenib API Revenue by Application (2023-2028) & (US$ Million)
Table 50. Global Sorafenib API Revenue Share by Application (2017-2022)
Table 51. Global Sorafenib API Revenue Share by Application (2023-2028)
Table 52. Sorafenib API Price by Application (2017-2022) & (US$/Kg)
Table 53. Global Sorafenib API Price Forecast by Application (2023-2028) & (US$/Kg)
Table 54. North America Sorafenib API Sales by Purity (2017-2022) & (Tons)
Table 55. North America Sorafenib API Sales by Purity (2023-2028) & (Tons)
Table 56. North America Sorafenib API Revenue by Purity (2017-2022) & (US$ Million)
Table 57. North America Sorafenib API Revenue by Purity (2023-2028) & (US$ Million)
Table 58. North America Sorafenib API Sales by Application (2017-2022) & (Tons)
Table 59. North America Sorafenib API Sales by Application (2023-2028) & (Tons)
Table 60. North America Sorafenib API Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Sorafenib API Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Sorafenib API Sales by Country (2017-2022) & (Tons)
Table 63. North America Sorafenib API Sales by Country (2023-2028) & (Tons)
Table 64. North America Sorafenib API Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Sorafenib API Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Sorafenib API Sales by Purity (2017-2022) & (Tons)
Table 67. Europe Sorafenib API Sales by Purity (2023-2028) & (Tons)
Table 68. Europe Sorafenib API Revenue by Purity (2017-2022) & (US$ Million)
Table 69. Europe Sorafenib API Revenue by Purity (2023-2028) & (US$ Million)
Table 70. Europe Sorafenib API Sales by Application (2017-2022) & (Tons)
Table 71. Europe Sorafenib API Sales by Application (2023-2028) & (Tons)
Table 72. Europe Sorafenib API Revenue by Application (2017-2022) & (US$ Million)
Table 73. Europe Sorafenib API Revenue by Application (2023-2028) & (US$ Million)
Table 74. Europe Sorafenib API Sales by Country (2017-2022) & (Tons)
Table 75. Europe Sorafenib API Sales by Country (2023-2028) & (Tons)
Table 76. Europe Sorafenib API Revenue by Country (2017-2022) & (US$ Million)
Table 77. Europe Sorafenib API Revenue by Country (2023-2028) & (US$ Million)
Table 78. Asia Pacific Sorafenib API Sales by Purity (2017-2022) & (Tons)
Table 79. Asia Pacific Sorafenib API Sales by Purity (2023-2028) & (Tons)
Table 80. Asia Pacific Sorafenib API Revenue by Purity (2017-2022) & (US$ Million)
Table 81. Asia Pacific Sorafenib API Revenue by Purity (2023-2028) & (US$ Million)
Table 82. Asia Pacific Sorafenib API Sales by Application (2017-2022) & (Tons)
Table 83. Asia Pacific Sorafenib API Sales by Application (2023-2028) & (Tons)
Table 84. Asia Pacific Sorafenib API Revenue by Application (2017-2022) & (US$ Million)
Table 85. Asia Pacific Sorafenib API Revenue by Application (2023-2028) & (US$ Million)
Table 86. Asia Pacific Sorafenib API Sales by Region (2017-2022) & (Tons)
Table 87. Asia Pacific Sorafenib API Sales by Region (2023-2028) & (Tons)
Table 88. Asia Pacific Sorafenib API Revenue by Region (2017-2022) & (US$ Million)
Table 89. Asia Pacific Sorafenib API Revenue by Region (2023-2028) & (US$ Million)
Table 90. Latin America Sorafenib API Sales by Purity (2017-2022) & (Tons)
Table 91. Latin America Sorafenib API Sales by Purity (2023-2028) & (Tons)
Table 92. Latin America Sorafenib API Revenue by Purity (2017-2022) & (US$ Million)
Table 93. Latin America Sorafenib API Revenue by Purity (2023-2028) & (US$ Million)
Table 94. Latin America Sorafenib API Sales by Application (2017-2022) & (Tons)
Table 95. Latin America Sorafenib API Sales by Application (2023-2028) & (Tons)
Table 96. Latin America Sorafenib API Revenue by Application (2017-2022) & (US$ Million)
Table 97. Latin America Sorafenib API Revenue by Application (2023-2028) & (US$ Million)
Table 98. Latin America Sorafenib API Sales by Country (2017-2022) & (Tons)
Table 99. Latin America Sorafenib API Sales by Country (2023-2028) & (Tons)
Table 100. Latin America Sorafenib API Revenue by Country (2017-2022) & (US$ Million)
Table 101. Latin America Sorafenib API Revenue by Country (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Sorafenib API Sales by Purity (2017-2022) & (Tons)
Table 103. Middle East and Africa Sorafenib API Sales by Purity (2023-2028) & (Tons)
Table 104. Middle East and Africa Sorafenib API Revenue by Purity (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Sorafenib API Revenue by Purity (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Sorafenib API Sales by Application (2017-2022) & (Tons)
Table 107. Middle East and Africa Sorafenib API Sales by Application (2023-2028) & (Tons)
Table 108. Middle East and Africa Sorafenib API Revenue by Application (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Sorafenib API Revenue by Application (2023-2028) & (US$ Million)
Table 110. Middle East and Africa Sorafenib API Sales by Country (2017-2022) & (Tons)
Table 111. Middle East and Africa Sorafenib API Sales by Country (2023-2028) & (Tons)
Table 112. Middle East and Africa Sorafenib API Revenue by Country (2017-2022) & (US$ Million)
Table 113. Middle East and Africa Sorafenib API Revenue by Country (2023-2028) & (US$ Million)
Table 114. Hunan Huateng Pharmaceutical Corporation Information
Table 115. Hunan Huateng Pharmaceutical Description and Major Businesses
Table 116. Hunan Huateng Pharmaceutical Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 117. Hunan Huateng Pharmaceutical Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Hunan Huateng Pharmaceutical Recent Development
Table 119. Anhui HaiKang Pharmaceutical Corporation Information
Table 120. Anhui HaiKang Pharmaceutical Description and Major Businesses
Table 121. Anhui HaiKang Pharmaceutical Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 122. Anhui HaiKang Pharmaceutical Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Anhui HaiKang Pharmaceutical Recent Development
Table 124. Chongqing Carelife Pharmaceutical Corporation Information
Table 125. Chongqing Carelife Pharmaceutical Description and Major Businesses
Table 126. Chongqing Carelife Pharmaceutical Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 127. Chongqing Carelife Pharmaceutical Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Chongqing Carelife Pharmaceutical Recent Development
Table 129. Sichuan Xieli Pharmaceutical Corporation Information
Table 130. Sichuan Xieli Pharmaceutical Description and Major Businesses
Table 131. Sichuan Xieli Pharmaceutical Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 132. Sichuan Xieli Pharmaceutical Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Sichuan Xieli Pharmaceutical Recent Development
Table 134. NEWEDGE Overseas Corporation Information
Table 135. NEWEDGE Overseas Description and Major Businesses
Table 136. NEWEDGE Overseas Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 137. NEWEDGE Overseas Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. NEWEDGE Overseas Recent Development
Table 139. KriSan Biotech Corporation Information
Table 140. KriSan Biotech Description and Major Businesses
Table 141. KriSan Biotech Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 142. KriSan Biotech Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. KriSan Biotech Recent Development
Table 144. Teva API Corporation Information
Table 145. Teva API Description and Major Businesses
Table 146. Teva API Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 147. Teva API Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Teva API Recent Development
Table 149. Alembic Pharmaceuticals Corporation Information
Table 150. Alembic Pharmaceuticals Description and Major Businesses
Table 151. Alembic Pharmaceuticals Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 152. Alembic Pharmaceuticals Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Alembic Pharmaceuticals Recent Development
Table 154. Aurobindo Pharma Corporation Information
Table 155. Aurobindo Pharma Description and Major Businesses
Table 156. Aurobindo Pharma Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 157. Aurobindo Pharma Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Aurobindo Pharma Recent Development
Table 159. BDR Pharmaceuticals Corporation Information
Table 160. BDR Pharmaceuticals Description and Major Businesses
Table 161. BDR Pharmaceuticals Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 162. BDR Pharmaceuticals Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. BDR Pharmaceuticals Recent Development
Table 164. Biotechnica Pharma Global Corporation Information
Table 165. Biotechnica Pharma Global Description and Major Businesses
Table 166. Biotechnica Pharma Global Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 167. Biotechnica Pharma Global Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Biotechnica Pharma Global Recent Development
Table 169. Bulat Pharmaceutical Corporation Information
Table 170. Bulat Pharmaceutical Description and Major Businesses
Table 171. Bulat Pharmaceutical Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 172. Bulat Pharmaceutical Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Bulat Pharmaceutical Recent Development
Table 174. Cdymax Corporation Information
Table 175. Cdymax Description and Major Businesses
Table 176. Cdymax Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 177. Cdymax Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Cdymax Recent Development
Table 179. Estechpharma Corporation Information
Table 180. Estechpharma Description and Major Businesses
Table 181. Estechpharma Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 182. Estechpharma Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Estechpharma Recent Development
Table 184. Jeil Pharmaceutical Corporation Information
Table 185. Jeil Pharmaceutical Description and Major Businesses
Table 186. Jeil Pharmaceutical Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 187. Jeil Pharmaceutical Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Jeil Pharmaceutical Recent Development
Table 189. MSN Laboratories Corporation Information
Table 190. MSN Laboratories Description and Major Businesses
Table 191. MSN Laboratories Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 192. MSN Laboratories Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. MSN Laboratories Recent Development
Table 194. Stason Pharmaceuticals Corporation Information
Table 195. Stason Pharmaceuticals Description and Major Businesses
Table 196. Stason Pharmaceuticals Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 197. Stason Pharmaceuticals Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 198. Stason Pharmaceuticals Recent Development
Table 199. Vannsh Life Sciences Corporation Information
Table 200. Vannsh Life Sciences Description and Major Businesses
Table 201. Vannsh Life Sciences Sorafenib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 202. Vannsh Life Sciences Sorafenib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 203. Vannsh Life Sciences Recent Development
Table 204. Key Raw Materials Lists
Table 205. Raw Materials Key Suppliers Lists
Table 206. Sorafenib API Distributors List
Table 207. Sorafenib API Customers List
Table 208. Sorafenib API Market Trends
Table 209. Sorafenib API Market Drivers
Table 210. Sorafenib API Market Challenges
Table 211. Sorafenib API Market Restraints
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
List of Figures
Figure 1. Sorafenib API Product Picture
Figure 2. Global Sorafenib API Market Share by Purity in 2021 & 2028
Figure 3. 0.99 Product Picture
Figure 4. 0.995 Product Picture
Figure 5. 0.999 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Sorafenib API Market Share by Application in 2021 & 2028
Figure 8. Tablets
Figure 9. Others
Figure 10. Sorafenib API Report Years Considered
Figure 11. Global Sorafenib API Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 12. Global Sorafenib API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Sorafenib API Production Market Share by Region (2017-2022)
Figure 14. Global Sorafenib API Production Market Share by Region (2023-2028)
Figure 15. Sorafenib API Production Growth Rate in North America (2017-2028) & (Tons)
Figure 16. Sorafenib API Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 17. Sorafenib API Production Growth Rate in China (2017-2028) & (Tons)
Figure 18. Sorafenib API Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 19. Global Sorafenib API Sales 2017-2028 (Tons)
Figure 20. Global Sorafenib API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Sorafenib API Revenue 2017-2028 (US$ Million)
Figure 22. Global Sorafenib API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 23. Global Sorafenib API Sales Market Share by Region (2017-2022)
Figure 24. Global Sorafenib API Sales Market Share by Region (2023-2028)
Figure 25. North America Sorafenib API Sales YoY (2017-2028) & (Tons)
Figure 26. North America Sorafenib API Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Europe Sorafenib API Sales YoY (2017-2028) & (Tons)
Figure 28. Europe Sorafenib API Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Sorafenib API Sales YoY (2017-2028) & (Tons)
Figure 30. Asia-Pacific Sorafenib API Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Latin America Sorafenib API Sales YoY (2017-2028) & (Tons)
Figure 32. Latin America Sorafenib API Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Middle East & Africa Sorafenib API Sales YoY (2017-2028) & (Tons)
Figure 34. Middle East & Africa Sorafenib API Revenue YoY (2017-2028) & (US$ Million)
Figure 35. The Sorafenib API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 36. The Top 5 and 10 Largest Manufacturers of Sorafenib API in the World: Market Share by Sorafenib API Revenue in 2021
Figure 37. Sorafenib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 38. Global Sorafenib API Sales Market Share by Purity (2017-2028)
Figure 39. Global Sorafenib API Revenue Market Share by Purity (2017-2028)
Figure 40. Global Sorafenib API Sales Market Share by Application (2017-2028)
Figure 41. Global Sorafenib API Revenue Market Share by Application (2017-2028)
Figure 42. North America Sorafenib API Sales Market Share by Purity (2017-2028)
Figure 43. North America Sorafenib API Revenue Market Share by Purity (2017-2028)
Figure 44. North America Sorafenib API Sales Market Share by Application (2017-2028)
Figure 45. North America Sorafenib API Revenue Market Share by Application (2017-2028)
Figure 46. North America Sorafenib API Sales Share by Country (2017-2028)
Figure 47. North America Sorafenib API Revenue Share by Country (2017-2028)
Figure 48. United States Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 49. Canada Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 50. Europe Sorafenib API Sales Market Share by Purity (2017-2028)
Figure 51. Europe Sorafenib API Revenue Market Share by Purity (2017-2028)
Figure 52. Europe Sorafenib API Sales Market Share by Application (2017-2028)
Figure 53. Europe Sorafenib API Revenue Market Share by Application (2017-2028)
Figure 54. Europe Sorafenib API Sales Share by Country (2017-2028)
Figure 55. Europe Sorafenib API Revenue Share by Country (2017-2028)
Figure 56. Germany Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 57. France Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 58. U.K. Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 59. Italy Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 60. Russia Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 61. Asia Pacific Sorafenib API Sales Market Share by Purity (2017-2028)
Figure 62. Asia Pacific Sorafenib API Revenue Market Share by Purity (2017-2028)
Figure 63. Asia Pacific Sorafenib API Sales Market Share by Application (2017-2028)
Figure 64. Asia Pacific Sorafenib API Revenue Market Share by Application (2017-2028)
Figure 65. Asia Pacific Sorafenib API Sales Share by Region (2017-2028)
Figure 66. Asia Pacific Sorafenib API Revenue Share by Region (2017-2028)
Figure 67. China Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 68. Japan Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 69. South Korea Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 70. India Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 71. Australia Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 72. China Taiwan Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 73. Indonesia Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 74. Thailand Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 75. Malaysia Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 76. Latin America Sorafenib API Sales Market Share by Purity (2017-2028)
Figure 77. Latin America Sorafenib API Revenue Market Share by Purity (2017-2028)
Figure 78. Latin America Sorafenib API Sales Market Share by Application (2017-2028)
Figure 79. Latin America Sorafenib API Revenue Market Share by Application (2017-2028)
Figure 80. Latin America Sorafenib API Sales Share by Country (2017-2028)
Figure 81. Latin America Sorafenib API Revenue Share by Country (2017-2028)
Figure 82. Mexico Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 83. Brazil Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 84. Argentina Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 85. Colombia Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 86. Middle East and Africa Sorafenib API Sales Market Share by Purity (2017-2028)
Figure 87. Middle East and Africa Sorafenib API Revenue Market Share by Purity (2017-2028)
Figure 88. Middle East and Africa Sorafenib API Sales Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Sorafenib API Revenue Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Sorafenib API Sales Share by Country (2017-2028)
Figure 91. Middle East and Africa Sorafenib API Revenue Share by Country (2017-2028)
Figure 92. Turkey Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 93. Saudi Arabia Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 94. UAE Sorafenib API Revenue (2017-2028) & (US$ Million)
Figure 95. Sorafenib API Value Chain
Figure 96. Sorafenib API Production Process
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed